Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
HCP-targeted ads in DTC spaces
-
Can a digital ad on a platform available to consumers but targeted to HCPs (i.e., an HCP-targeted ad on LinkedIn) include both brand name & a brief message about new study data being available (including the study name) be included in the ad if there is sufficient space for fair balance?
If this is too specific, can you provide guidance or clarity around the limits of what can be said in branded APS that are targeted to HCPs but appear in DTC-accessible spaces like LinkedIn?
Thank you so much,
Maryssa -
Hey @Maryssa
Any ad which appears in the consumer space (even when limited through targeting based on interests or profession), are subject to the direct-to-consumer advertising regulations. Link to therapeutic use through study design, name, description, fair balance, or any other form, would not be acceptable since it would contravene Section C.01.044 of the Food and Drugs Act and Regulations which does not permit advertising of prescription medications to the general public beyond name, price and quantity.
